25 XP   0   0   10

China Biotech Services Holdings Ltd
Buy, Hold or Sell?

Let's analyse China Biotech Services Holdings Ltd together

PenkeI guess you are interested in China Biotech Services Holdings Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of China Biotech Services Holdings Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about China Biotech Services Holdings Ltd

I send you an email if I find something interesting about China Biotech Services Holdings Ltd.

Quick analysis of China Biotech Services Holdings Ltd (30 sec.)










What can you expect buying and holding a share of China Biotech Services Holdings Ltd? (30 sec.)

How much money do you get?

How much money do you get?
HK$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
HK$0.51
Expected worth in 1 year
HK$0.04
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
HK$-0.46
Return On Investment
-178.8%

For what price can you sell your share?

Current Price per Share
HK$0.26
Expected price per share
HK$0 - HK$0.51
How sure are you?
50%

1. Valuation of China Biotech Services Holdings Ltd (5 min.)




Live pricePrice per Share (EOD)

HK$0.26

Intrinsic Value Per Share

HK$-1.63 - HK$3.12

Total Value Per Share

HK$-1.12 - HK$3.63

2. Growth of China Biotech Services Holdings Ltd (5 min.)




Is China Biotech Services Holdings Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$62.6m$76.9m-$14.2m-22.8%

How much money is China Biotech Services Holdings Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$12.1m$32.9m-$45.1m-370.4%
Net Profit Margin-45.0%13.9%--

How much money comes from the company's main activities?

3. Financial Health of China Biotech Services Holdings Ltd (5 min.)




4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#81 / 145

Most Revenue
#83 / 145

Most Profit
#114 / 145

What can you expect buying and holding a share of China Biotech Services Holdings Ltd? (5 min.)

Welcome investor! China Biotech Services Holdings Ltd's management wants to use your money to grow the business. In return you get a share of China Biotech Services Holdings Ltd.

What can you expect buying and holding a share of China Biotech Services Holdings Ltd?

First you should know what it really means to hold a share of China Biotech Services Holdings Ltd. And how you can make/lose money.

Speculation

The Price per Share of China Biotech Services Holdings Ltd is HK$0.26. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of China Biotech Services Holdings Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in China Biotech Services Holdings Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is HK$0.51. Based on the TTM, the Book Value Change Per Share is HK$-0.12 per quarter. Based on the YOY, the Book Value Change Per Share is HK$0.14 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is HK$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of China Biotech Services Holdings Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 HK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per Share
Usd Eps-0.01-4.9%-0.01-4.9%0.0313.2%0.001.2%0.00-1.1%
Usd Book Value Change Per Share-0.01-5.7%-0.01-5.7%0.027.0%0.001.8%0.001.8%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.01-5.7%-0.01-5.7%0.027.0%0.001.8%0.001.8%
Usd Price Per Share0.10-0.10-0.15-0.15-0.12-
Price to Earnings Ratio-7.77--7.77-4.29-18.84-3.95-
Price-to-Total Gains Ratio-6.63--6.63-8.10--36.57--19.79-
Price to Book Ratio1.51-1.51-1.84-2.52-2.46-
Price-to-Total Gains Ratio-6.63--6.63-8.10--36.57--19.79-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.033202
Number of shares30118
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.010.00
Usd Total Gains Per Share-0.010.00
Gains per Quarter (30118 shares)-447.00137.20
Gains per Year (30118 shares)-1,788.00548.82
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1788-17980549539
20-3576-3586010981088
30-5364-5374016461637
40-7152-7162021952186
50-8940-8950027442735
60-10728-10738032933284
70-12516-12526038423833
80-14304-14314043914382
90-16092-16102049394931
100-17880-17890054885480

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%3.07.00.030.0%6.015.00.028.6%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%5.05.00.050.0%11.010.00.052.4%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%4.00.017.019.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%5.05.00.050.0%11.010.00.052.4%

Fundamentals of China Biotech Services Holdings Ltd

About China Biotech Services Holdings Ltd

China Biotech Services Holdings Limited, an investment holding company, provides medical laboratory testing and health check services in the People's Republic of China and Hong Kong. The company operates through six segments: Medical and Health Related Services, Immunotherapy, Pharmaceutical Products, Securities, Insurance brokerage, BNCT, and Others segments. It also engages in the provision of medical laboratory testing services and health check services; provision of tumor immune cell therapy and health management services; sale and distribution of health related and pharmaceutical products; trading of securities; insurance brokerage services; provision of boron neutron capture therapy services; and money lending business and provision of logistic services. The company was formerly known as Rui Kang Pharmaceutical Group Investments Limited and changed its name to China Biotech Services Holdings Limited in November 2017. China Biotech Services Holdings Limited was founded in 1996 and is headquartered in Causeway Bay, Hong Kong.

Fundamental data was last updated by Penke on 2024-04-18 19:01:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of China Biotech Services Holdings Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit China Biotech Services Holdings Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare China Biotech Services Holdings Ltd to the Diagnostics & Research industry mean.
  • A Net Profit Margin of -45.0% means that $-0.45 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of China Biotech Services Holdings Ltd:

  • The MRQ is -45.0%. The company is making a huge loss. -2
  • The TTM is -45.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-45.0%TTM-45.0%0.0%
TTM-45.0%YOY13.9%-59.0%
TTM-45.0%5Y-38.1%-7.0%
5Y-38.1%10Y-64.1%+26.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-45.0%-6.7%-38.3%
TTM-45.0%-6.7%-38.3%
YOY13.9%0.3%+13.6%
5Y-38.1%-1.5%-36.6%
10Y-64.1%-3.4%-60.7%
1.1.2. Return on Assets

Shows how efficient China Biotech Services Holdings Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare China Biotech Services Holdings Ltd to the Diagnostics & Research industry mean.
  • -14.4% Return on Assets means that China Biotech Services Holdings Ltd generated $-0.14 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of China Biotech Services Holdings Ltd:

  • The MRQ is -14.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -14.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-14.4%TTM-14.4%0.0%
TTM-14.4%YOY17.6%-32.0%
TTM-14.4%5Y-2.9%-11.5%
5Y-2.9%10Y-10.8%+7.9%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-14.4%-1.3%-13.1%
TTM-14.4%-1.3%-13.1%
YOY17.6%-0.9%+18.5%
5Y-2.9%-0.5%-2.4%
10Y-10.8%-0.9%-9.9%
1.1.3. Return on Equity

Shows how efficient China Biotech Services Holdings Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare China Biotech Services Holdings Ltd to the Diagnostics & Research industry mean.
  • -20.6% Return on Equity means China Biotech Services Holdings Ltd generated $-0.21 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of China Biotech Services Holdings Ltd:

  • The MRQ is -20.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -20.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-20.6%TTM-20.6%0.0%
TTM-20.6%YOY42.8%-63.4%
TTM-20.6%5Y0.3%-21.0%
5Y0.3%10Y-13.0%+13.4%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-20.6%-0.5%-20.1%
TTM-20.6%--20.6%
YOY42.8%0.3%+42.5%
5Y0.3%-1.4%+1.7%
10Y-13.0%-2.3%-10.7%

1.2. Operating Efficiency of China Biotech Services Holdings Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient China Biotech Services Holdings Ltd is operating .

  • Measures how much profit China Biotech Services Holdings Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare China Biotech Services Holdings Ltd to the Diagnostics & Research industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of China Biotech Services Holdings Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-16.2%+16.2%
5Y-16.2%10Y-38.8%+22.6%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ--6.2%+6.2%
TTM-0.5%-0.5%
YOY-4.0%-4.0%
5Y-16.2%3.7%-19.9%
10Y-38.8%-1.3%-37.5%
1.2.2. Operating Ratio

Measures how efficient China Biotech Services Holdings Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 2.40 means that the operating costs are $2.40 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of China Biotech Services Holdings Ltd:

  • The MRQ is 2.398. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.398. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.398TTM2.3980.000
TTM2.398YOY0.947+1.451
TTM2.3985Y1.613+0.785
5Y1.61310Y1.614-0.001
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.3981.280+1.118
TTM2.3981.304+1.094
YOY0.9471.236-0.289
5Y1.6131.242+0.371
10Y1.6141.205+0.409

1.3. Liquidity of China Biotech Services Holdings Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if China Biotech Services Holdings Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 1.64 means the company has $1.64 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of China Biotech Services Holdings Ltd:

  • The MRQ is 1.638. The company is able to pay all its short-term debts. +1
  • The TTM is 1.638. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.638TTM1.6380.000
TTM1.638YOY1.613+0.025
TTM1.6385Y1.544+0.094
5Y1.54410Y3.315-1.771
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6382.111-0.473
TTM1.6382.298-0.660
YOY1.6132.599-0.986
5Y1.5443.012-1.468
10Y3.3153.081+0.234
1.3.2. Quick Ratio

Measures if China Biotech Services Holdings Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare China Biotech Services Holdings Ltd to the Diagnostics & Research industry mean.
  • A Quick Ratio of 0.25 means the company can pay off $0.25 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of China Biotech Services Holdings Ltd:

  • The MRQ is 0.249. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.249. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.249TTM0.2490.000
TTM0.249YOY1.564-1.316
TTM0.2495Y1.199-0.950
5Y1.19910Y2.776-1.577
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2491.204-0.955
TTM0.2491.319-1.070
YOY1.5641.602-0.038
5Y1.1991.943-0.744
10Y2.7762.203+0.573

1.4. Solvency of China Biotech Services Holdings Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of China Biotech Services Holdings Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare China Biotech Services Holdings Ltd to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.26 means that China Biotech Services Holdings Ltd assets are financed with 25.9% credit (debt) and the remaining percentage (100% - 25.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of China Biotech Services Holdings Ltd:

  • The MRQ is 0.259. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.259. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.259TTM0.2590.000
TTM0.259YOY0.590-0.331
TTM0.2595Y0.374-0.115
5Y0.37410Y0.292+0.082
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2590.429-0.170
TTM0.2590.407-0.148
YOY0.5900.394+0.196
5Y0.3740.450-0.076
10Y0.2920.450-0.158
1.4.2. Debt to Equity Ratio

Measures if China Biotech Services Holdings Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare China Biotech Services Holdings Ltd to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 37.1% means that company has $0.37 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of China Biotech Services Holdings Ltd:

  • The MRQ is 0.371. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.371. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.371TTM0.3710.000
TTM0.371YOY1.440-1.069
TTM0.3715Y0.784-0.413
5Y0.78410Y0.555+0.229
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3710.606-0.235
TTM0.3710.571-0.200
YOY1.4400.631+0.809
5Y0.7840.658+0.126
10Y0.5550.735-0.180

2. Market Valuation of China Biotech Services Holdings Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings China Biotech Services Holdings Ltd generates.

  • Above 15 is considered overpriced but always compare China Biotech Services Holdings Ltd to the Diagnostics & Research industry mean.
  • A PE ratio of -7.77 means the investor is paying $-7.77 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of China Biotech Services Holdings Ltd:

  • The EOD is -2.624. Based on the earnings, the company is expensive. -2
  • The MRQ is -7.771. Based on the earnings, the company is expensive. -2
  • The TTM is -7.771. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.624MRQ-7.771+5.147
MRQ-7.771TTM-7.7710.000
TTM-7.771YOY4.292-12.063
TTM-7.7715Y18.839-26.610
5Y18.83910Y3.947+14.892
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-2.624-0.235-2.389
MRQ-7.771-0.395-7.376
TTM-7.771-0.284-7.487
YOY4.2920.002+4.290
5Y18.8394.834+14.005
10Y3.9475.200-1.253
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of China Biotech Services Holdings Ltd:

  • The EOD is 1.893. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 5.606. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 5.606. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD1.893MRQ5.606-3.713
MRQ5.606TTM5.6060.000
TTM5.606YOY2.682+2.924
TTM5.6065Y5.313+0.292
5Y5.31310Y-9.178+14.492
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD1.893-0.277+2.170
MRQ5.606-0.441+6.047
TTM5.606-1.389+6.995
YOY2.682-2.030+4.712
5Y5.313-1.446+6.759
10Y-9.178-1.971-7.207
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of China Biotech Services Holdings Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 1.51 means the investor is paying $1.51 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of China Biotech Services Holdings Ltd:

  • The EOD is 0.510. Based on the equity, the company is cheap. +2
  • The MRQ is 1.511. Based on the equity, the company is underpriced. +1
  • The TTM is 1.511. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.510MRQ1.511-1.001
MRQ1.511TTM1.5110.000
TTM1.511YOY1.838-0.327
TTM1.5115Y2.524-1.012
5Y2.52410Y2.456+0.067
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD0.5101.897-1.387
MRQ1.5112.222-0.711
TTM1.5112.168-0.657
YOY1.8383.041-1.203
5Y2.5243.477-0.953
10Y2.4564.125-1.669
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of China Biotech Services Holdings Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.116-0.1160%0.142-182%0.036-426%0.038-409%
Book Value Per Share--0.5090.5090%0.626-19%0.494+3%0.391+30%
Current Ratio--1.6381.6380%1.613+2%1.544+6%3.315-51%
Debt To Asset Ratio--0.2590.2590%0.590-56%0.374-31%0.292-11%
Debt To Equity Ratio--0.3710.3710%1.440-74%0.784-53%0.555-33%
Dividend Per Share----0%-0%-0%-0%
Eps---0.099-0.0990%0.268-137%0.024-519%-0.022-78%
Free Cash Flow Per Share--0.1370.1370%0.429-68%0.172-20%0.060+130%
Free Cash Flow To Equity Per Share--0.1370.1370%0.136+1%0.072+90%0.064+114%
Gross Profit Margin--1.0001.0000%1.0000%0.947+6%1.114-10%
Intrinsic Value_10Y_max--3.123--------
Intrinsic Value_10Y_min---1.632--------
Intrinsic Value_1Y_max--0.224--------
Intrinsic Value_1Y_min--0.004--------
Intrinsic Value_3Y_max--0.740--------
Intrinsic Value_3Y_min---0.134--------
Intrinsic Value_5Y_max--1.339--------
Intrinsic Value_5Y_min---0.429--------
Market Cap250440053.760-196%741687985.500741687985.5000%1107715650.000-33%1135384159.500-35%910217014.816-19%
Net Profit Margin---0.450-0.4500%0.139-423%-0.381-15%-0.641+42%
Operating Margin----0%-0%-0.1620%-0.3880%
Operating Ratio--2.3982.3980%0.947+153%1.613+49%1.614+49%
Pb Ratio0.510-196%1.5111.5110%1.838-18%2.524-40%2.456-38%
Pe Ratio-2.624+66%-7.771-7.7710%4.292-281%18.839-141%3.947-297%
Price Per Share0.260-196%0.7700.7700%1.150-33%1.176-35%0.944-18%
Price To Free Cash Flow Ratio1.893-196%5.6065.6060%2.682+109%5.313+6%-9.178+264%
Price To Total Gains Ratio-2.237+66%-6.625-6.6250%8.099-182%-36.571+452%-19.791+199%
Quick Ratio--0.2490.2490%1.564-84%1.199-79%2.776-91%
Return On Assets---0.144-0.1440%0.176-182%-0.029-80%-0.108-25%
Return On Equity---0.206-0.2060%0.428-148%0.003-6138%-0.130-37%
Total Gains Per Share---0.116-0.1160%0.142-182%0.036-426%0.038-409%
Usd Book Value--62665710.20062665710.2000%76961597.500-19%60906872.560+3%48153818.350+30%
Usd Book Value Change Per Share---0.015-0.0150%0.018-182%0.005-426%0.005-409%
Usd Book Value Per Share--0.0650.0650%0.080-19%0.063+3%0.050+30%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.013-0.0130%0.034-137%0.003-519%-0.003-78%
Usd Free Cash Flow--16895859.30016895859.3000%52739844.600-68%21232372.520-20%7364791.020+129%
Usd Free Cash Flow Per Share--0.0180.0180%0.055-68%0.022-20%0.008+130%
Usd Free Cash Flow To Equity Per Share--0.0180.0180%0.017+1%0.009+90%0.008+114%
Usd Market Cap31981194.865-196%94713555.74894713555.7480%141455288.505-33%144988557.168-35%116234712.792-19%
Usd Price Per Share0.033-196%0.0980.0980%0.147-33%0.150-35%0.120-18%
Usd Profit---12188581.900-12188581.9000%32957709.900-137%2894959.000-521%-2672390.670-78%
Usd Revenue--27070484.50027070484.5000%236440636.400-89%86894333.360-69%49021476.000-45%
Usd Total Gains Per Share---0.015-0.0150%0.018-182%0.005-426%0.005-409%
 EOD+4 -4MRQTTM+0 -0YOY+8 -245Y+13 -2010Y+15 -18

3.2. Fundamental Score

Let's check the fundamental score of China Biotech Services Holdings Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.624
Price to Book Ratio (EOD)Between0-10.510
Net Profit Margin (MRQ)Greater than0-0.450
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.249
Current Ratio (MRQ)Greater than11.638
Debt to Asset Ratio (MRQ)Less than10.259
Debt to Equity Ratio (MRQ)Less than10.371
Return on Equity (MRQ)Greater than0.15-0.206
Return on Assets (MRQ)Greater than0.05-0.144
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of China Biotech Services Holdings Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5030.462
Ma 20Greater thanMa 500.312
Ma 50Greater thanMa 1000.411
Ma 100Greater thanMa 2000.513
OpenGreater thanClose0.250
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in HKD. All numbers in thousands.

Summary
Total Assets662,362
Total Liabilities171,636
Total Stockholder Equity462,754
 As reported
Total Liabilities 171,636
Total Stockholder Equity+ 462,754
Total Assets = 662,362

Assets

Total Assets662,362
Total Current Assets261,166
Long-term Assets401,196
Total Current Assets
Cash And Cash Equivalents 72,087
Net Receivables 39,636
Inventory 9,274
Total Current Assets  (as reported)261,166
Total Current Assets  (calculated)120,997
+/- 140,169
Long-term Assets
Property Plant Equipment 112,047
Goodwill 107,181
Intangible Assets 69,812
Long-term Assets  (as reported)401,196
Long-term Assets  (calculated)289,040
+/- 112,156

Liabilities & Shareholders' Equity

Total Current Liabilities159,467
Long-term Liabilities12,169
Total Stockholder Equity462,754
Total Current Liabilities
Short Long Term Debt 84,840
Accounts payable 5,787
Other Current Liabilities 432
Total Current Liabilities  (as reported)159,467
Total Current Liabilities  (calculated)91,059
+/- 68,408
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt15,556
Long-term Liabilities  (as reported)12,169
Long-term Liabilities  (calculated)15,556
+/- 3,387
Total Stockholder Equity
Total Stockholder Equity (as reported)462,754
Total Stockholder Equity (calculated)0
+/- 462,754
Other
Capital Stock96,323
Common Stock Shares Outstanding 963,231
Net Debt 12,753
Net Invested Capital 547,594
Net Working Capital 101,699
Property Plant and Equipment Gross 282,961



Balance Sheet

Currency in HKD. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312013-09-302012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-31
> Total Assets 
191,430
214,928
266,805
245,037
248,330
155,070
247,518
195,829
190,925
264,972
274,380
327,016
478,018
322,956
303,400
337,761
416,584
904,121
706,782
1,470,491
662,362
662,3621,470,491706,782904,121416,584337,761303,400322,956478,018327,016274,380264,972190,925195,829247,518155,070248,330245,037266,805214,928191,430
   > Total Current Assets 
0
181,541
198,704
174,079
172,079
92,588
191,038
159,829
172,218
188,000
198,225
228,706
334,494
145,977
181,975
217,982
86,443
446,313
277,774
884,757
261,166
261,166884,757277,774446,31386,443217,982181,975145,977334,494228,706198,225188,000172,218159,829191,03892,588172,079174,079198,704181,5410
       Cash And Cash Equivalents 
34,847
34,672
28,760
11,125
11,751
2,128
88,443
25,065
38,277
46,565
32,092
39,163
75,234
34,695
73,181
154,479
45,518
384,539
150,554
92,770
72,087
72,08792,770150,554384,53945,518154,47973,18134,69575,23439,16332,09246,56538,27725,06588,4432,12811,75111,12528,76034,67234,847
       Short-term Investments 
0
1,774
5,132
9,615
3,946
5,675
19,485
38,798
66,713
44,050
51,476
18,697
54,793
53,844
2,966
2,569
1,317
1,270
1,759
0
0
001,7591,2701,3172,5692,96653,84454,79318,69751,47644,05066,71338,79819,4855,6753,9469,6155,1321,7740
       Net Receivables 
50,454
59,188
62,316
43,830
53,004
41,058
28,326
19,199
11,797
16,203
47,765
45,163
22,529
34,736
58,428
39,492
29,292
47,489
105,939
765,547
39,636
39,636765,547105,93947,48929,29239,49258,42834,73622,52945,16347,76516,20311,79719,19928,32641,05853,00443,83062,31659,18850,454
       Other Current Assets 
0
0
11,013
18,115
14,334
8,159
18,692
18,426
10,772
28,349
52,223
76,387
165,742
11,845
34,280
13,428
3,329
5,862
9,522
7,145
0
07,1459,5225,8623,32913,42834,28011,845165,74276,38752,22328,34910,77218,42618,6928,15914,33418,11511,01300
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
176,979
121,425
119,779
330,141
457,808
429,008
585,734
401,196
401,196585,734429,008457,808330,141119,779121,425176,9790000000000000
       Property Plant Equipment 
31,328
33,561
47,545
50,197
52,513
46,291
44,966
28,986
14,150
18,053
17,874
46,816
31,005
41,421
41,428
22,954
36,918
147,659
105,494
128,855
112,047
112,047128,855105,494147,65936,91822,95441,42841,42131,00546,81617,87418,05314,15028,98644,96646,29152,51350,19747,54533,56131,328
       Goodwill 
0
0
5,525
5,525
5,640
0
0
0
0
45,192
24,439
2,478
29,411
1,742
264
264
115,343
117,595
120,554
110,083
107,181
107,181110,083120,554117,595115,3432642641,74229,4112,47824,43945,19200005,6405,5255,52500
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
28,789
22,963
15,919
69,364
26,897
53,125
82,622
0
0
0
0
000082,62253,12526,89769,36415,91922,96328,7890000000000
       Intangible Assets 
0
0
5,525
20,761
23,738
16,191
11,514
7,014
4,557
59,068
24,439
26,053
67,189
64,452
52,836
43,436
95,258
88,072
80,939
67,313
69,812
69,81267,31380,93988,07295,25843,43652,83664,45267,18926,05324,43959,0684,5577,01411,51416,19123,73820,7615,52500
       Other Assets 
0
0
15,031
0
0
0
0
0
0
0
5,053
13,884
8,619
7,842
8,175
0
0
5,637
0
180,321
0
0180,32105,637008,1757,8428,61913,8845,053000000015,03100
> Total Liabilities 
52,634
50,967
89,831
98,352
113,789
105,892
100,801
98,100
84,110
106,180
146,189
129,103
135,280
47,739
52,092
18,846
103,221
392,016
240,887
867,816
171,636
171,636867,816240,887392,016103,22118,84652,09247,739135,280129,103146,189106,18084,11098,100100,801105,892113,78998,35289,83150,96752,634
   > Total Current Liabilities 
52,634
50,967
74,369
98,352
110,724
102,827
100,801
98,100
84,110
106,180
146,189
129,103
133,268
42,833
45,735
15,837
53,759
272,314
227,395
548,664
159,467
159,467548,664227,395272,31453,75915,83745,73542,833133,268129,103146,189106,18084,11098,100100,801102,827110,72498,35274,36950,96752,634
       Short-term Debt 
0
0
0
0
0
5,675
19,485
38,798
66,713
41,000
59,185
18,697
54,793
53,844
2,966
2,569
1,317
10,664
56,038
5,641
0
05,64156,03810,6641,3172,5692,96653,84454,79318,69759,18541,00066,71338,79819,4855,67500000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
41,000
59,185
29,718
1,917
18,854
26,784
3,267
28,850
10,664
56,038
5,641
84,840
84,8405,64156,03810,66428,8503,26726,78418,8541,91729,71859,18541,000000000000
       Accounts payable 
7,872
12,184
28,311
33,447
36,805
36,885
19,527
22,699
8,623
22,676
25,764
21,048
4,270
8,390
5,057
2,151
3,404
190,233
16,149
206,441
5,787
5,787206,44116,149190,2333,4042,1515,0578,3904,27021,04825,76422,6768,62322,69919,52736,88536,80533,44728,31112,1847,872
       Other Current Liabilities 
35,328
24,821
40,149
34,552
38,962
37,698
62,179
35,909
47,779
42,666
22,985
34,495
119,869
10,856
9,425
1,516
3,381
46,342
119,443
377
432
432377119,44346,3423,3811,5169,42510,856119,86934,49522,98542,66647,77935,90962,17937,69838,96234,55240,14924,82135,328
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
4,906
6,357
3,009
49,462
119,702
13,492
95,307
12,169
12,16995,30713,492119,70249,4623,0096,3574,9060000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
3,120
4,759
1,603
6,085
83,078
3,556
65,163
0
065,1633,55683,0786,0851,6034,7593,1200000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
2,012
1,786
1,598
1,406
43,377
36,624
9,936
30,144
0
030,1449,93636,62443,3771,4061,5981,7862,012000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
447
0
0
0
0
0
0
0
0
0
0
00000000004470000000000
> Total Stockholder Equity
138,796
163,961
171,568
140,973
127,148
42,964
141,993
95,324
106,497
158,792
128,191
169,270
321,058
265,510
254,674
324,077
289,192
343,331
395,398
602,675
462,754
462,754602,675395,398343,331289,192324,077254,674265,510321,058169,270128,191158,792106,49795,324141,99342,964127,148140,973171,568163,961138,796
   Common Stock
50,000
50,000
50,000
50,000
53,340
53,340
96,008
96,008
115,208
3,144
3,144
10,056
65,699
78,837
85,637
93,535
96,981
96,685
96,323
96,323
0
096,32396,32396,68596,98193,53585,63778,83765,69910,0563,1443,144115,20896,00896,00853,34053,34050,00050,00050,00050,000
   Retained Earnings 
58,208
83,373
77,816
45,637
7,450
0
0
-154,708
0
-116,000
-147,410
-235,542
-297,811
-303,557
-366,579
-432,215
-531,060
-493,604
-475,133
18,333
-310,798
-310,79818,333-475,133-493,604-531,060-432,215-366,579-303,557-297,811-235,542-147,410-116,0000-154,708007,45045,63777,81683,37358,208
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
443,140
498,852
495,840
490,692
490,692
0
0490,692490,692495,840498,852443,140000000000000000
   Treasury Stock000-1,20000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
272,457
262,451
263,621
211,162
215,798
219,617
224,419
245,610
283,516
-10,695
0
0-10,695283,516245,610224,419219,617215,798211,162263,621262,451272,4570000000000



Balance Sheet

Currency in HKD. All numbers in thousands.




Cash Flow

Currency in HKD. All numbers in thousands.




Income Statement

Currency in HKD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue211,985
Cost of Revenue-177,661
Gross Profit34,32434,324
 
Operating Income (+$)
Gross Profit34,324
Operating Expense-330,613
Operating Income-118,628-296,289
 
Operating Expense (+$)
Research Development0
Selling General Administrative152,952
Selling And Marketing Expenses0
Operating Expense330,613152,952
 
Net Interest Income (+$)
Interest Income3,742
Interest Expense-5,311
Other Finance Cost-0
Net Interest Income-1,569
 
Pretax Income (+$)
Operating Income-118,628
Net Interest Income-1,569
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-142,025-118,628
EBIT - interestExpense = -5,311
-95,447
-90,136
Interest Expense5,311
Earnings Before Interest and Taxes (EBIT)0-136,714
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-142,025
Tax Provision--1,319
Net Income From Continuing Ops-140,706-140,706
Net Income-95,447
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net01,569
 

Technical Analysis of China Biotech Services Holdings Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of China Biotech Services Holdings Ltd. The general trend of China Biotech Services Holdings Ltd is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine China Biotech Services Holdings Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of China Biotech Services Holdings Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.265 < 0.395 < 0.51.

The bearish price targets are: .

Tweet this
China Biotech Services Holdings Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of China Biotech Services Holdings Ltd. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

China Biotech Services Holdings Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of China Biotech Services Holdings Ltd. The current macd is -0.04358328.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the China Biotech Services Holdings Ltd price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for China Biotech Services Holdings Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the China Biotech Services Holdings Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
China Biotech Services Holdings Ltd Daily Moving Average Convergence/Divergence (MACD) ChartChina Biotech Services Holdings Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of China Biotech Services Holdings Ltd. The current adx is 8.53216442.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell China Biotech Services Holdings Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
China Biotech Services Holdings Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of China Biotech Services Holdings Ltd. The current sar is 0.2856327.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
China Biotech Services Holdings Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of China Biotech Services Holdings Ltd. The current rsi is 30.46. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -3/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
China Biotech Services Holdings Ltd Daily Relative Strength Index (RSI) ChartChina Biotech Services Holdings Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of China Biotech Services Holdings Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the China Biotech Services Holdings Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
China Biotech Services Holdings Ltd Daily Stochastic Oscillator ChartChina Biotech Services Holdings Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of China Biotech Services Holdings Ltd. The current cci is -92.71523179.

China Biotech Services Holdings Ltd Daily Commodity Channel Index (CCI) ChartChina Biotech Services Holdings Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of China Biotech Services Holdings Ltd. The current cmo is -48.55848884.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
China Biotech Services Holdings Ltd Daily Chande Momentum Oscillator (CMO) ChartChina Biotech Services Holdings Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of China Biotech Services Holdings Ltd. The current willr is -92.59259259.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
China Biotech Services Holdings Ltd Daily Williams %R ChartChina Biotech Services Holdings Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of China Biotech Services Holdings Ltd.

China Biotech Services Holdings Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of China Biotech Services Holdings Ltd. The current atr is 0.02516973.

China Biotech Services Holdings Ltd Daily Average True Range (ATR) ChartChina Biotech Services Holdings Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of China Biotech Services Holdings Ltd. The current obv is -5,483,200.

China Biotech Services Holdings Ltd Daily On-Balance Volume (OBV) ChartChina Biotech Services Holdings Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of China Biotech Services Holdings Ltd. The current mfi is 34.46.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
China Biotech Services Holdings Ltd Daily Money Flow Index (MFI) ChartChina Biotech Services Holdings Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for China Biotech Services Holdings Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-11-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-06MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-28BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-29ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-02RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-19RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-01WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-21BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-22MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-24STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

China Biotech Services Holdings Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of China Biotech Services Holdings Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5030.462
Ma 20Greater thanMa 500.312
Ma 50Greater thanMa 1000.411
Ma 100Greater thanMa 2000.513
OpenGreater thanClose0.250
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of China Biotech Services Holdings Ltd with someone you think should read this too:
  • Are you bullish or bearish on China Biotech Services Holdings Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about China Biotech Services Holdings Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about China Biotech Services Holdings Ltd

I send you an email if I find something interesting about China Biotech Services Holdings Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about China Biotech Services Holdings Ltd.

Receive notifications about China Biotech Services Holdings Ltd in your mailbox!